Form 4: Pacific Biosciences Director Kathy Ordonez Reports Acquisition and Disposal of Shares

Sentiment:

SEC Form 4 Filing


Director Kathy Ordonez reports acquiring 22,821 shares of Pacific Biosciences common stock and disposing of 403,037 shares.

Summary

  • On June 18, 2024, Kathy Ordonez, a director of Pacific Biosciences, reported acquiring 22,821 shares of common stock represented by Restricted Stock Units (RSUs) at $0.
  • These RSUs will vest on the one-year anniversary of the grant date or the next annual meeting if earlier, contingent on continued service as a director.
  • Ordonez also disposed of 403,037 shares.
  • Additionally, Ordonez acquired options to buy 32,179 shares of common stock at an exercise price of $1.65, which vest monthly over one year, also contingent on continued service as a director.
  • Following these transactions, Ordonez directly owns 403,037 shares of common stock and options for 32,179 shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral. The acquisition of RSUs and options is mildly positive, but the disposal of shares is mildly negative. The overall impact is likely minimal.

Positives

  • The acquisition of RSUs and stock options by a director could be seen as a positive signal, indicating confidence in the company's future performance.

Negatives

  • The disposal of 403,037 shares by a director could be interpreted negatively by investors.

Risks

  • The vesting of RSUs and stock options is contingent on continued service as a director, creating a potential risk if Ordonez were to leave the company.
  • The disposal of a large number of shares by a director could indicate a lack of confidence in the company's future prospects.

Industry Context

This filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their transactions in the company's stock. It's important for investors to monitor these filings to understand the sentiment and actions of key individuals within the company.

Stakeholder Impact

  • Shareholders may react to the reported transactions, potentially influencing the stock price.
  • Employees may view the director's actions as a signal of confidence or concern regarding the company's prospects.

Key Dates

DateDescription
06/18/2024Date of the reported transactions: acquisition of RSUs and stock options, and disposal of shares.
07/18/2024First possible vesting date for stock options.
06/18/2034Expiration date for the stock options.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.